File Browser

NOVARTIS PHARMACEUTICALS CANADA INC. v. MYLAN PHARMACEUTICALS ULC ET AL.

Summary of T-365-14

The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.

Federal Court Type: S. 18.1 Patented Medicines (Notice of Compliance) Regulations

Parties and Lawyers:
PartyFirmLawyer
LTS LOHMANN THERAPIE SYSTEME AG
MINISTER OF HEALTH (THE)
MYLAN PHARMACEUTICALS ULC
NOVARTIS AG
NOVARTIS PHARMACEUTICALS CANADA INCGowling Lafleur Henderson LLPCREBER, TONY
NOVARTIS PHARMACEUTICALS CANADA INC
Intellectual Property:
NameNumber
2315784

Patented Medicine: Rivastigmine (Medicinal ingredients are based on automated analysis and should not be relied upon.)

Decisions

NameDateParagraph
Novartis Pharmaceuticals Canada Inc. v. Mylan Pharmaceuticals ULC 2016 FC 1091Sep 28, 2016A protective order was issued on consent of the parties in the context of this application for a prohibition order, brought pursuant to the PM(NOC) Regulations. This order covers Mylan’s information concerning its proposed rivastigmine transdermal patch, including any samples that may be provided voluntarily or by compulsion of a Court order, and any testing or analysis performed on or with such samples. It provides that Mylan’s information “shall be used solely for this proceeding as well as any appeal or other proceeding related thereto”. This application was resolved on consent of the parties in August 2015. Novartis now moves for an order amending the protective order so that it may use the samples it obtained from Mylan and the expert affidavits setting out the results and analysis of tests performed on those samples for the purposes of litigation taking place in Portugal between it and a company related to Mylan, involving the same rivastigmine transdermal patches. Mylan opposes the motion. ... In the circumstances, I am not satisfied that what Novartis proposes to do is a particularly fair use of this Court’s process and I find that the public interest is better served by dismissing Novartis’ motion to vary the terms of the protective order.


Docket Summary (Google Translate to English)

(104) 2017-03-24 - Ottawa
Certified French language Translation of ORDER AND REASONS rendered on 28-SEP-2016 by Mireille Tabib, Prothonotary filed on 24-MAR-2017 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of ORDER AND REASONS entered in J. & O. Book, volume 1330 page(s) 25 - 25 and copy placed on file.
() 2017-02-27 - Ottawa
Covering letter from Applicant dated 27-FEB-2017 concerning Doc. Nos. 102 103 placed on file on 27-FEB-2017
(103) 2017-02-27 - Ottawa
Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. 102 upon Applicant by courier on 27-FEB-2017 filed on 27-FEB-2017
(102) 2017-02-27 - Ottawa
Public Version of Document No. 85 (5 Volumes, further to 28-JAN-2015 Protective Order) filed on 27-FEB-2017
() 2016-10-28 - Ottawa
Covering letter from Respondent dated 28-OCT-2016 concerning Doc. No. 100 placed on file on 28-OCT-2016
(101) 2016-10-28 - Ottawa
Solicitor's certificate of service on behalf of Lilian A. Wallace confirming service of Doc. 100 upon all parties by email on 28-OCT-2016 filed on 28-OCT-2016
(100) 2016-10-28 - Ottawa
Public Version of Motion Record #96 (3 volumes) filed on 28-OCT-2016
() 2016-09-30 - Ottawa
Letter sent by Registry on 30-SEP-2016 to Nancy Gallinger, Law Clerk, Gowlings LLP enclosing DARS CD for proceeding heard September 21, 2016 Copy placed on file.
() 2016-09-30 - Ottawa
Request for a copy of DARS recording received on September 27, 2016 placed on file 30-sep-2016
() 2016-09-28 - Ottawa
Acknowledgment of Receipt received from all parties by email with respect to Doc. 99 placed on file on 28-SEP-2016
(99) 2016-09-28 - Ottawa
Reasons for Order and Order dated 28-SEP-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 85 Result: The motion is dismissed, with costs in the amount of $2,000 plus disbursements, payable by Novartis to Mylan. Filed on 28-SEP-2016 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1314 page(s) 107 - 118
() 2016-09-21 - Ottawa
Ottawa 21-SEP-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 85 on behalf of Applicant Result of Hearing: Matter dismissed held in Court Senior Usher: D. Martin Duration per day: 21-SEP-2016 from 09:30 to 13:18 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Julie Dulac Total Duration: .5d Appearances: John Norman and Alex Gloor 613-233-1781 representing Applicant Nathaniel Lipkus and Lillian Wallace 416-362-2111 representing Respondent Mylan Comments: DARS was used to record this hearing (Z008078) Minutes of Hearing entered in Vol. 957 page(s) 454 - 457 Abstract of Hearing placed on file
() 2016-09-20 - Ottawa
Covering letter from Respondent, Mylan Pharma ULC dated 20-SEP-2016 concerning Doc. Nos. 93 94 95 96 97 98 placed on file on 20-SEP-2016
(98) 2016-09-20 - Ottawa
Solicitor's certificate of service on behalf of Lillian A. Wallace confirming service of Motion Record (3 volumes) and Book of Authorities upon Applicant Respondent by personal service on 20-SEP-2016 filed on 20-SEP-2016
() 2016-09-20 - Ottawa
Book of Authorities consisting of 1 volume(s) on behalf of the respondent, Mylan Pharma received on 20-SEP-2016
(97) 2016-09-20 - Ottawa
Sealed envelope pursuant to Protective Order dated January 28, 2015 on behalf of Respondent, Mylan Pharma purporting to contain Motion Record (3 volumes) Docs 93, 94, 95,96 Filed on 20-SEP-2016
(96) 2016-09-20 - Ottawa
Motion Record containing the following original document(s): 93 94 95 Number of copies received: 3 on behalf of the respondent, Mylan Pharma ULC filed on 20-SEP-2016
(95) 2016-09-20 - Ottawa
Written Representations contained within a Motion Record on behalf of the Respondent Mylan Pharma ULC concerning in opposition to Motion Doc. No. 85 filed on 20-SEP-2016
(94) 2016-09-20 - Ottawa
Affidavit of Filipe Teixeira Baptista sworn on 19-SEP-2016 contained within a Motion Record on behalf of the Respondent Mylan Pharma ULC in opposition to Motion Doc. No. 85 filed on 20-SEP-2016
(93) 2016-09-20 - Ottawa
Affidavit of Faylene Lunn sworn on 19-SEP-2016 contained within a Motion Record on behalf of the Respondent, Mylan Pharma ULC in opposition to Motion Doc. No. 85 with Exhibits A to F filed on 20-SEP-2016
(92) 2016-09-19 - Ottawa
Solicitor's certificate of service on behalf of Alex Gloor confirming service of Book of Authorities upon all parties by courier on 19-SEP-2016 filed on 19-SEP-2016
() 2016-09-19 - Ottawa
Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 19-SEP-2016 Sent directly to Presiding Judge
() 2016-09-15 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Direction of the Court dated 15-Sep-2016 placed on file on 15-SEP-2016
() 2016-09-15 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-SEP-2016 directing that Novartis' motion to amend the Protective Order is scheduled to be heard in Ottawa, on September 21, 2016, beginning at 9:30 am. Mylan's responding motion record shall be served and filed by noon on September 20, 2016. Cross-examinations, if any, shall be conducted in the afternoon of September 20, unless the hearing can be rescheduled at a later date placed on file on 15-SEP-2016 Confirmed in writing to the party(ies)
() 2016-09-15 - Ottawa
Ottawa 15-SEP-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the scheduling of Novartis' motion to amend the Protective Order Result of Hearing: the motion is scheduled to be heard in Ottawa on September 21, 2016 at 9:30 for half a day held in chambers by way of Conference Call Duration per day: 15-SEP-2016 from 09:00 to 09:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 15min Appearances: Alex Gloor 613-786-0172 representing Applicant Vincent de Grandpré 416-862-6570 representing Defendant Mylan Lillian Wallace 613-787-1058 representing Defendant Mylan No appearance - representing the Minister Minutes of Hearing entered in Vol. 957 page(s) 235 - 237 Abstract of Hearing placed on file
() 2016-09-14 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Direction of the Court dated 14-Sep-2016 placed on file on 14-SEP-2016
() 2016-09-14 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-SEP-2016 directing that a case management telephone conference will be held at 9:00 am on Thursday, September 15, 2016 placed on file on 14-SEP-2016 Confirmed in writing to the party(ies)
() 2016-09-14 - Ottawa
Letter from Applicant dated 14-SEP-2016 regarding confidential motion record doc. 90, requesting leave to file the public version of the motion record later this week and requesting a hearing date for the motion on an urgent basis received on 14-SEP-2016
(91) 2016-09-14 - Ottawa
Solicitor's certificate of service on behalf of John Norman confirming service of Confidential Motion Record doc. 90 upon Mylan Pharmaceuticals ULC and the Minister of Health by courier on 14-SEP-2016 filed on 14-SEP-2016
() 2016-09-14 - Ottawa
Sealed envelope pursuant to Confidentiality Order dated January 28, 2015 on behalf of Applicant purporting to contain Motion Record doc. 90 Received on 14-SEP-2016
(90) 2016-09-14 - Ottawa
Motion Record containing the following original document(s): 85 86 87 88 89 Number of copies received: 3 on behalf of Applicant filed on 14-SEP-2016
(89) 2016-09-14 - Ottawa
Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 85 filed on 14-SEP-2016
(88) 2016-09-14 - Ottawa
Affidavit of Conrad Arnander sworn on 13-SEP-2016 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 85 with Exhibits A to E filed on 14-SEP-2016
(87) 2016-09-14 - Ottawa
Affidavit of Antonio de Magalhaes Cardoso sworn on 12-SEP-2016 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 85 with Exhibits A to I filed on 14-SEP-2016
(86) 2016-09-14 - Ottawa
Affidavit of Nancy Gallinger sworn on 12-SEP-2016 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 85 with Exhibits A to Q filed on 14-SEP-2016
(85) 2016-09-14 - Ottawa
Notice of Motion contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order amending the Protective Order and other relief filed on 14-SEP-2016 Draft Order\\Judgment received.
() 2016-09-14 - Ottawa
Communication to the Court from the Registry dated 14-SEP-2016 re: the Applicant's letter and notice of motion dated 12-Sep-2016
() 2016-09-12 - Ottawa
Covering letter from Applicant dated 12-SEP-2016 concerning Doc. No. 84 placed on file on 12-SEP-2016
(84) 2016-09-12 - Ottawa
Notice of Motion on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order amending the Protective Order filed on 12-SEP-2016
() 2015-07-03 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Order dated 2-Jul-2015 placed on file on 03-JUL-2015
(83) 2015-07-02 - Ottawa
Order dated 02-JUL-2015 rendered by The Honourable Mr. Justice Barnes Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 29-JUN-2015 Result: granted Filed on 02-JUL-2015 copies sent to parties entered in J. & O. Book, volume 1271 page(s) 195 - 196 Final Decision
() 2015-06-30 - Ottawa
Communication to the Court from the Registry dated 30-JUN-2015 re: the Applicant's correspondence dated 29-Jun-2015
(82) 2015-06-29 - Ottawa
Consent on behalf of all parties to the draft prohibition order filed on 29-JUN-2015
() 2015-06-29 - Ottawa
Letter from Applicant dated 29-JUN-2015 advising that the parties have reached a settlement and providing a draft prohibition order on consent received on 29-JUN-2015
() 2015-06-19 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Direction of the Court dated 19-Jun-2015 placed on file on 19-JUN-2015
() 2015-06-19 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 19-JUN-2015 directing that further to the Applicant's correspondence dated June 17, 2015 requesting a two week extension of time to serve and file the Applicant's Application Record, "extension granted as requested" placed on file on 19-JUN-2015 Confirmed in writing to the party(ies)
() 2015-06-18 - Ottawa
Communication to the Court from the Registry dated 18-JUN-2015 re: the Applicant's letter dated June 17, 2015 (sent to the CMJ and the Judicial Administrator)
() 2015-06-18 - Ottawa
Letter from Applicant dated 17-JUN-2015 requesting an extension of time to serve and file their application record to allow parties time to finalize settlement received on 18-JUN-2015
() 2015-05-07 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Direction of the Court dated 6-May-2015 placed on file on 07-MAY-2015
() 2015-05-06 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAY-2015 directing that extension granted as requested. As filing dates are unaffected a formal order will not be issued placed on file on 06-MAY-2015 Confirmed in writing to the party(ies)
() 2015-05-06 - Ottawa
Communication to the Court from the Registry dated 06-MAY-2015 re: the Applicant's letter dated 6-May-2015
() 2015-05-06 - Ottawa
Letter from Applicant dated 06-MAY-2015 requesting a extension of time to complete cross-examinations received on 06-MAY-2015
(81) 2015-03-19 - Ottawa
Solicitor's certificate of service on behalf of John Norman confirming service of Revised Reply Affidavit of Mark Lautens upon all parties by telecopier on 19-MAR-2015 filed on 19-MAR-2015
() 2015-02-26 - Toronto
Acknowledgment of Receipt received from all parties with respect to Order docs 79 and 80 placed on file on 26-FEB-2015
(80) 2015-02-26 - Toronto
Order dated 26-FEB-2015 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 64 Result: dismissed Filed on 26-FEB-2015 certified copies sent to parties entered in J. & O. Book, volume 1259 page(s) 214 - 216 Interlocutory Decision
(79) 2015-02-26 - Toronto
Order dated 26-FEB-2015 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 58 Result: granted in part Filed on 26-FEB-2015 certified copies sent to parties entered in J. & O. Book, volume 1259 page(s) 192 - 201 Interlocutory Decision
() 2015-02-19 - Ottawa
Ottawa 19-FEB-2015 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 58 on behalf of Applicant Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 64 on behalf of Respondent, Mylan, Result of Hearing: Matter dismissed held in Court Duration per day: 19-FEB-2015 from 09:38 to 12:58 Courtroom : Courtroom No. 702, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Victoria Bell Total Duration: 3h 20 mins Appearances: Mr. John Norman / Mr. Adam Heckman 613-783-8848 representing Applicant Mr. Vincent de Grandpré / Ms. Faylene Lunn 416-862-6743 representing Respondent, Mylan, *** no one appearing representing Respondent, Minister of Health *** Comments: The Digital Audio Recording System (Z005239) was used to record this hearing Minutes of Hearing entered in Vol. 922 page(s) 336 - 355 Abstract of Hearing placed on file
(78) 2015-02-18 - Ottawa
Solicitor's certificate of service on behalf of Adam Heckman confirming service of document id 149 upon Respondent Mylan Pharmaceuticals ULC by courier on 18-FEB-2015 confirming service document id 149 upon Respondent Minister of Health by e-mail on consent on 18-FEB-2015 filed on 18-FEB-2015
() 2015-02-18 - Ottawa
Book of Authorities re: Responding Motion to Strike consisting of 1 volume(s) on behalf of Applicant received on 18-FEB-2015 Sent directly to Presiding Judge
() 2015-02-17 - Ottawa
Covering letter from Applicant dated 17-FEB-2015 concerning Doc. Nos. 74 75 76 placed on file on 17-FEB-2015
(77) 2015-02-17 - Ottawa
Solicitor's certificate of service on behalf of Adam Heckman confirming service of Doc. Nos. 74,75,76 upon all parties by electronic mail on 17-FEB-2015 filed on 17-FEB-2015
() 2015-02-17 - Ottawa
Public version of Responding Motion Record of the Applicant (Doc.Nos. 74 to 76 received on 17-FEB-2015
(76) 2015-02-17 - Ottawa
Sealed envelope pursuant to protective order dated March 6, 2015 on behalf of Applicant purporting to contain Respondents Motion Record (contains doc. Nos 74 and 75 Filed on 17-FEB-2015
(75) 2015-02-17 - Ottawa
Written Representations contained within a Motion Record on behalf of Applicant concerning In response to Motion doc. No. 64 filed on 17-FEB-2015
(74) 2015-02-17 - Ottawa
Affidavit of Erin McIntomny sworn on 28-JAN-2015 contained within a Motion Record on behalf of Applicant in opposition to Motion Doc. No. 64 with Exhibits A to O filed on 17-FEB-2015
() 2015-02-17 - Ottawa
Covering letter from Respondent, Mylan Pharma ULC dated 17-FEB-2015 concerning Doc. Nos. 69 70 71 72 placed on file on 17-FEB-2015
(73) 2015-02-17 - Ottawa
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of Documents 69 to 72 upon all parties by hand and by e mail on 17-FEB-2015 filed on 17-FEB-2015
() 2015-02-17 - Ottawa
Book of Authorities consisting of 1 volume(s) on behalf of Respondent, Mylan Pharma ULC (in support of Docs 69 to 72) received on 17-FEB-2015
() 2015-02-17 - Ottawa
Public Version of Documents 69 to 72 (Volumes 1 and 2) received on 17-FEB-2015
(72) 2015-02-17 - Ottawa
Sealed envelope pursuant to Protective Order dated March 6, 2014. on behalf of Respondent, Mylan Pharma ULC purporting to contain Written Representations (Doc. 71) in opposition to Motion Doc. No. 58 Filed on 17-FEB-2015
(71) 2015-02-17 - Ottawa
Written Representations contained within a Motion Record on behalf of Respondent concerning in response to Motion Doc. No 58. filed on 17-FEB-2015
(70) 2015-02-17 - Ottawa
Sealed envelope pursuant to Protective Order dated March 6, 2014 on behalf of Respondent Mylan Pharma ULC purporting to contain Affidavit of Brad Jenkins sworn on February 17, 2015. with Exhibits A to K Filed on 17-FEB-2015
(69) 2015-02-17 - Ottawa
Affidavit of Brad Jenkins sworn on 17-FEB-2015 contained within a Motion Record on behalf of Respondent, Mylan Pharma ULC in opposition to Motion Doc. No. 58 with Exhibits A to K filed on 17-FEB-2015
(68) 2015-02-13 - Ottawa
Solicitor's certificate of service on behalf of Faylene Lunn confirming service of The Motion to strike on behalf of the Respondent/doc 64 upon The Applicant and the Respondent/Patentees by personal service on 13-FEB-2015 confirming service The Motion to Strike on behalf of the Respondent/dco 64 upon Respondent, Minster of Health. by electronic mail on 13-FEB-2015 filed on 13-FEB-2015
(67) 2015-02-13 - Ottawa
Motion Record containing the following original document(s): 64 65 66 Number of copies received: 3 on behalf of Respondent, Mylan Pharmaceuticals ULC filed on 13-FEB-2015
(66) 2015-02-13 - Ottawa
Written Representations contained within a Motion Record on behalf of The Respondent, Mylan Pharmaceutical ULC concerning Motion Doc. No. 64 filed on 13-FEB-2015
(65) 2015-02-13 - Ottawa
Affidavit of Brad Jenkins sworn on 13-FEB-2015 on behalf of The Respondent, Mylan Pharmaceuticals ULC in support of Motion Doc. No. 64 with Exhibits A-C filed on 13-FEB-2015
(64) 2015-02-13 - Ottawa
Notice of Motion contained within a Motion Record on behalf of The Respondent, Mylan Pharmaceuticals ULC ("Mylan") requesting the motion be returnable on Thursday February 19, 2015 at 9:30 for an Order to strike the affidavit of Erin McIntomny filed on 13-FEB-2015
() 2015-02-13 - Ottawa
Covering letter from The Respondent, Mylan Pharmaceuticals ULC dated 13-FEB-2015 concerning for a motion to be heard on February 19, 2015 at 9:30 a.m. Further to the direction of Madam Prothonotary Tabib, dated January 22, 2015 the parties to this proceeding are already scheduled to be before the Court on February 19, 2015 at 9:30 a.m. on a motion for leave to file reply evidence placed on file on 13-FEB-2015
() 2015-01-30 - Ottawa
Covering letter from Applicant dated 30-JAN-2015 concerning Doc. Nos. 61 62 63 placed on file on 30-JAN-2015
(63) 2015-01-30 - Ottawa
Solicitor's certificate of service on behalf of Adam Heckman confirming service of the Applicant's motion record (motion for reply) upon Respondent, Mylan, by courier on 30-JAN-2015 confirming service the Applicant's motion record (motion for reply) upon Respondent, Minister of Health, by electronic means (on consent) on 30-JAN-2015 filed on 30-JAN-2015
() 2015-01-30 - Ottawa
Book of Authorities consisting of 1 volume(s) on behalf of Applicant received on 30-JAN-2015
() 2015-01-30 - Ottawa
Public version of Motion Record doc. 61 (Novartis' motion for leave to file reply affidavits) 1 vol. - 1 copy only contains public versions of docs. 58, 59, 60 received on 30-JAN-2015
(62) 2015-01-30 - Ottawa
Sealed envelope pursuant to the Order of January 28, 2015 on behalf of Applicant purporting to contain the confidential version of Novartis' motion record for leave to file reply affidavits (contains docs. 58, 59, 60, 61) - 2 vols. (sealed) Filed on 30-JAN-2015
(61) 2015-01-30 - Ottawa
Motion Record containing the following original document(s): 58 59 60 Number of copies received: 3 on behalf of the Applicant (confidential version) filed on 30-JAN-2015
(60) 2015-01-30 - Ottawa
Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 58 filed on 30-JAN-2015
(59) 2015-01-30 - Ottawa
Affidavit of Erin McIntomny sworn on 28-JAN-2015 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 58 with Exhibits A-Z and AA-LL (exhibits Q, W, Y, AA, HH, II, LL entirely confidential) filed on 30-JAN-2015
(58) 2015-01-30 - Ottawa
Notice of Motion contained within a Motion Record on behalf of Applicant returnable at Special Sitting in Ottawa on 19-FEB-2015 to begin at 09:30 for an Order granting Novartis leave to serve and file the reply affidavits of Dr. Mark Lautens and Dr. Shen Luk (attached as confidential to the notice of motion) ; costs of the motion filed on 30-JAN-2015
() 2015-01-29 - Ottawa
Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Order of the Court dated 28-JAN-2015 placed on file on 29-JAN-2015
(57) 2015-01-28 - Ottawa
Order dated 28-JAN-2015 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 23-JAN-2015 re: requesting the issuance of a confidentiality Order Result: granted Filed on 28-JAN-2015 copies sent to parties entered in J. & O. Book, volume 1257 page(s) 68 - 71 Interlocutory Decision
(56) 2015-01-30 - Ottawa
Affidavit of service of Adam Hecman sworn on 30-JAN-2015 on behalf of Applicant confirming service of the Responding Evidence consisting of the Affidavit of Dr. Shen Luk, Dr. Amon and Erin Mcintommy upon Respondents by courier to Mylan Pharmaceuticals and electronically (on consent) to DOJ on 30-JAN-2015 filed on 30-JAN-2015
() 2015-01-26 - Ottawa
Communication to the Court from the Registry dated 26-JAN-2015 re: Respondent, Mylan's, request on consent for the issuance of an Order for confidentiality
() 2015-01-23 - Ottawa
Draft Order concerning the Respondent, Mylan's, request on consent for a confidentiality Order received on 23-JAN-2015
(55) 2015-01-23 - Ottawa
Affidavit of David E. Blais sworn on 23-JAN-2015 on behalf of Respondent, Mylan, in support of the request for a Confidentiality Order filed on 23-JAN-2015
(54) 2015-01-23 - Ottawa
Consent on behalf of all parties to the issuance of a Confidentiality Order filed on 23-JAN-2015
() 2015-01-23 - Ottawa
Letter from Respondent, Mylan, dated 23-JAN-2015 further to the Court's Orders of March 6, 2014 and July 10, 2014, with consent of all parties, requesting that the Court dispense with the need to file a formal motion record and accept the request for the issuance of a confidentiality Order as set out in the draft Order. The letter also includes submissions as to confidentiality of information. The Respondent, Mylan, requests that the confidentiality Order be issued by January 30, 2015. received on 23-JAN-2015
() 2015-01-23 - Ottawa
Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Direction of the Court dated 22-JAN-2015 placed on file on 23-JAN-2015
() 2015-01-22 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 22-JAN-2015 directing that "Extension granted as requested. The motion for leave to file reply evidence will be heard in Ottawa beginning at 9:30am on February 19, 2015 for one half day." placed on file on 22-JAN-2015 Confirmed in writing to the party(ies)
() 2015-01-21 - Ottawa
Communication to the Court from the Registry dated 21-JAN-2015 re: letter received from the Applicant dated 16-JAN-2015
() 2015-01-16 - Ottawa
Letter from Applicant dated 16-JAN-2015 requesting an extension of time to file their full motion for reply to January 30, 2015 and advising of the parties' dates of availability for the hearing of the motion as well as the anticipated duration. received on 16-JAN-2015
() 2014-12-19 - Ottawa
Covering letter from Faylene Lunn for the Respondent, Mylan Pharmaceuticals ULC dated 19-DEC-2014 concerning Doc. No. 53 placed on file on 19-DEC-2014
(53) 2014-12-19 - Ottawa
Solicitor's certificate of service on behalf of Faylene A. Lunn confirming service of the Confidential Affidavits of M. W. Powell, J. M. Chong, D. Sutherland, M. Foldvari, C. F. Poole, L. Wallace, D. Blais upon the Applicant and the Respondents/Patentees by personal service on 19-DEC-2014 confirming service the Confidential Affidavits of M. W. Powell, J. M. Chong, D. Sutherland, M. Foldvari, C. F. Poole, L. Wallace, D. Blais upon the Respondent, Minister of Health by email and by sending electronic copies of the affidavits and exhibits on CD on 19-DEC-2014 filed on 19-DEC-2014
() 2014-10-31 - Ottawa
Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Order of the Court dated 31-OCT-2014 placed on file on 31-OCT-2014
(52) 2014-10-31 - Ottawa
Order dated 31-OCT-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Respondent dated 27-OCT-2014 Result: "1. Mylan Pharmaceuticals ULC's Rule 307 evidence shall be served by December 19, 2014. 2. A full motion record on any motion for reply shall be filed by January 19, 2015. Such motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 3. To the extent that Mylan conducts testing of its rivastigmine product at any point in this proceeding of which Novartis is not in receipt of the full results by at least July 1, 2014, Novartis shall have a right to serve responding evidence. Any such evidence shall be served no later than January 30, 2015. 4. Cross-examinations sahll be completed by May 8, 2015. 5. Novartis' Application Record shall be served and filed by June 19, 2015. 6. Mylan's Application Record shall be served and filed by July 31, 2015. 7. There shall be no costs of this Order." Filed on 31-OCT-2014 copies sent to parties entered in J. & O. Book, volume 1247 page(s) 132 - 134 Interlocutory Decision
() 2014-10-30 - Ottawa
Communication to the Court from the Registry dated 30-OCT-2014 re: letters received from the Respondent, Mylan, and Applicant dated October 27 and 29, 2014 respectively
() 2014-10-29 - Ottawa
Letter from Applicant dated 29-OCT-2014 in response to the letter from counsel for Mylan dated 27-OCT-2014 received on 29-OCT-2014
() 2014-10-27 - Ottawa
Letter from Respondent dated 27-OCT-2014 requesting an extension of time for service of the R. 307 affidavits. Mylan has not been able to get consent of the Applicants to this request and have provided dates of availability for a case conference should the Court require one. A draft Order is attached. received on 27-OCT-2014
() 2014-10-03 - Ottawa
Confirmation of successful transmission by fax on behalf of all parties with regard to Order of Place and Time dated October 3, 2014. placed on file on 03-OCT-2014
(51) 2014-10-03 - Ottawa
Order (time and place) dated 03-OCT-2014 rendered by G. Calamo, Judicial Administrator fixing Judicial Review (s.18) to be heard at Special Sitting in Ottawa on 14-SEP-2015 to begin at 09:30 duration: 3j language: E Filed on 03-OCT-2014 cc's sent to parties entered in J. & O. Book, volume 1244 page(s) 400 - 401 Transmittal letters placed on file
() 2014-09-24 - Ottawa
Communication to the Court from the Registry dated 24-SEP-2014 re: Sent to JA's office for a hearing date to be set down.
(50) 2014-09-22 - Ottawa
Solicitor's certificate of service on behalf of Alex Gloor confirming service of the Requisition for Hearing upon the Respondents, Mylan Pharmaceuticals ULC and the Minister of Health by telecopier on 22-SEP-2014 filed on 22-SEP-2014
(49) 2014-09-22 - Ottawa
Requisition for hearing - Application from Applicant filed on 22-SEP-2014 Tariff Application or appeal - $50.00
() 2014-07-30 - Ottawa
Acknowledgment of Receipt received from all parties via email with respect to the Order of 29-JUL-2014 (Doc. 48) placed on file on 30-JUL-2014
(48) 2014-07-29 - Ottawa
Order dated 29-JUL-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 18-JUL-2014 Result: - Novartis shall serve its affidavit evidence on infringement by 5-AUG-14; - A Requisition for Hearing shall be filed by 22-SEP-14; - Mylan shall serve its affidavit evidence on infringement by 31-OCT-14; - A full motion record on any motion for reply shall be filed by 14-NOV-14; - To the extent that Mylan conducts any testing of its rivastigmine product at any point in this proceeding of which Novartis is not in receipt of the full results by at least 1-JUL-14, Novartis shall have a right to serve reponding evidence in response thereto within 30 days of receipt of the full results of Mylan's testing; - Cross-exams shall be completed by 2-MAR-2015; - Novartis' Application record shall be served and filed by 31-MAR-15; Mylan's Application record shall be served and filed 30-APR-15. Filed on 29-JUL-2014 copies sent to parties entered in J. & O. Book, volume 1238 page(s) 343 - 344 Interlocutory Decision
() 2014-07-24 - Ottawa
Communication to the Court from the Registry dated 24-JUL-2014 re: revised draft scheduling Order on consent received July 18, 2014
() 2014-07-18 - Ottawa
Letter from Applicant dated 18-JUL-2014 attaching a revised draft scheduling Order on consent of Mylan. A draft Order is attached. received on 18-JUL-2014
() 2014-07-23 - Toronto
Correction to General Sitting concerning Motion Doc. No. 34 Hearing removed from General Sitting at Toronto on 22-JUL-2014 Reason for correction: ORDER ISSUED ON CONSENT OF ALL PARTIES (SEE DOC. 46)
(47) 2014-07-21 - Toronto
Consent on behalf of all parties to DRAFT ORDER FOR THIRD PARTY'S MOTION DOC. 34 filed on 21-JUL-2014
() 2014-07-23 - Toronto
Acknowledgment of Receipt received from APPLICANT - NOVARTIS AND RESPONDENT - MOH with respect to ORDER OF THE HONOURABLE MR. JUSTICE O'REILLY DATED 22-JUL-2014 (DOC. 46) placed on file on 23-JUL-2014
() 2014-07-22 - Toronto
Acknowledgment of Receipt received from THIRD PARTY - HENKEL AND RESPONDENT - MYLAN with respect to ORDER OF THE HONOURABLE MR. JUSTICE O'REILLY DATED 22-JUL-2014 (DOC. 46) placed on file on 22-JUL-2014
(46) 2014-07-22 - Toronto
Order dated 22-JUL-2014 rendered by The Honourable Mr. Justice O'Reilly Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 34 Result: granted Filed on 22-JUL-2014 copies sent to parties entered in J. & O. Book, volume 1238 page(s) 40 - 41 Interlocutory Decision
() 2014-07-16 - Ottawa
Letter from Third Party dated 16-JUL-2014 re: having Motion doc. #34 filed on July 14 put on the General Sittings list in Toronto on July 22, 2014 received on 16-JUL-2014
() 2014-07-15 - Ottawa
Acknowledgment of Receipt received from Applicant with respect to doc. #45 placed on file on 15-JUL-2014
() 2014-07-15 - Ottawa
Acknowledgment of Receipt received from Respondent - Mylan Pharmaceuticals with respect to doc. #45 placed on file on 15-JUL-2014
() 2014-07-15 - Ottawa
Acknowledgment of Receipt received from Third Party with respect to doc. #45 placed on file on 15-JUL-2014
() 2014-07-16 - Ottawa
Correction to General Sitting concerning Motion Doc. No. 34 Hearing added to General Sitting at Toronto on 22-JUL-2014 at 09:30 duration: 2h Language: E Reason for correction: Order of the Court dated July 15, 2015
(45) 2014-07-15 - Ottawa
Order dated 15-JUL-2014 rendered by The Honourable Mr. Justice Annis Matter considered without personal appearance The Court's decision is with regard to Letter from Third Party dated 15-JUL-2014 re: letter dated July 15, 2014 seeking an order to furthe extend the Stay Order until the Henkel Motion can be heard on its merits Result: granted Filed on 15-JUL-2014 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1237 page(s) 238 - 240 Interlocutory Decision
() 2014-07-15 - Ottawa
Letter from Third Party dated 15-JUL-2014 re: request of an order further extending the stay of July 10, 2014 until the Third Party's motion can be heard on its merits received on 15-JUL-2014
() 2014-07-15 - Ottawa
Letter from Third Party dated 15-JUL-2014 re: pursuant the direction of the Court dated July 15, 2014 received on 15-JUL-2014
(44) 2014-07-15 - Ottawa
Solicitor's certificate of service on behalf of Alex Gloor confirming service of the Responding Motion Record of the Applicant, Novartis Pharmaceuticals Canada Inc. upon all parties by email on consent (with hard copy to follow via courier) on 15-JUL-2014 filed on 15-JUL-2014
(43) 2014-07-15 - Ottawa
Motion Record in response to Motion Doc. No. 34 containing the following original document(s): 42 Number of copies received: 3 on behalf of Applicant, Novartis Pharmaceuticals Canada Inc. filed on 15-JUL-2014
(42) 2014-07-15 - Ottawa
Written Representations contained within a Motion Record on behalf of Applicant, Novartis Pharmaceuticals Canada Inc. concerning Motion Doc. No. 34 filed on 15-JUL-2014
() 2014-07-15 - Ottawa
Correction to General Sitting concerning Motion Doc. No. 34 Hearing removed from General Sitting at Ottawa on 16-JUL-2014 Reason for correction: Direction of the Court dated July 15, 2014.
() 2014-07-15 - Ottawa
Oral directions received from the presiding judge dated 15-JUL-2014 directing that "The motion on behalf of Henkel Corporation appealing the Order of Prothonotary Tabib dated July 10, 2014 will not proceed at tomorrow's general sitting in Ottawa on short notice. The matter may be made returnable at another general sitting date." placed on file on 15-JUL-2014
() 2014-07-15 - Ottawa
Covering letter from Mr. Vincent M. de Grandpré dated 15-JUL-2014 concerning Doc. Nos. 40 41 placed on file on 15-JUL-2014
(41) 2014-07-15 - Ottawa
Solicitor's certificate of service on behalf of Martin E. Brandsma confirming service of the Motion Record of Mylan Pharmaceuticals ULC upon all parties by electronic mail on 15-JUL-2014 filed on 15-JUL-2014
(40) 2014-07-15 - Ottawa
Motion Record in response to Motion Doc. No. 34 containing the following original document(s): 39 Number of copies received: 3 on behalf of Respondent, Mylan Pharmaceuticals ULC filed on 15-JUL-2014
(39) 2014-07-15 - Ottawa
Written Representations contained within a Motion Record on behalf of Respondent, Mylan Pharmaceuticals ULC concerning Motion Doc. No. 34 filed on 15-JUL-2014
(38) 2014-07-14 - Toronto
Solicitor's certificate of service on behalf of Kristin Wall confirming service of Doc 36 and Book of Authorities upon all parties by personal service on 14-JUL-2014 filed on 14-JUL-2014
() 2014-07-14 - Toronto
Book of Authorities consisting of 1 volume(s) on behalf of Third Party received on 14-JUL-2014
(37) 2014-07-14 - Toronto
Motion Record containing the following original document(s): 34 35 36 Number of copies received: 3 on behalf of Third Party filed on 14-JUL-2014
(36) 2014-07-14 - Toronto
Written Representations contained within a Motion Record on behalf of Third Party concerning Motion Doc. No. 34 filed on 14-JUL-2014
(35) 2014-07-14 - Toronto
Affidavit of Sun Hee Lehmann sworn on 14-JUL-2014 contained within a Motion Record on behalf of Third Party in support of Motion Doc. No. 34 with Exhibits A-B filed on 14-JUL-2014
() 2014-07-14 - Toronto
Transcript of cross-examination held on 03-JUL-2014 RE: Affidavit of Sana Halwani received on 14-JUL-2014
() 2014-07-14 - Toronto
Transcript of cross-examination held on 02-JUL-2014 RE: Affidavit of Faylene Lunn received on 14-JUL-2014
() 2014-07-14 - Toronto
Transcript of cross-examination held on 02-JUL-2014 RE: Affidavit of Jennifer Wilkie received on 14-JUL-2014
(34) 2014-07-14 - Toronto
Notice of Motion contained within a Motion Record on behalf of Third Party returnable at General Sitting in Ottawa on 16-JUL-2014 to begin at 09:30 duration: 1h language: E with leave for short notice requested for an appeal of the decision of Mireille Tabib, Prothonotary dated 10-JUL-2014 filed on 14-JUL-2014
() 2014-07-10 - Ottawa
Acknowledgment of Receipt received from all parties and Henkel (by e-mail) with respect to the Order of the Court dated 10-JUL-2014 placed on file on 10-JUL-2014
() 2014-07-10 - Ottawa
Acknowledgment of Receipt received from all parties and Henkel (by e-mail) with respect to the Production and Confidentiality Order dated 10-JUL-2014 placed on file on 10-JUL-2014
(33) 2014-07-10 - Ottawa
Order dated 10-JUL-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from counsel for Henkel dated 10-JUL-2014 re: requesting an immediate direction that the material to be produced by Henkel be produced to "outside counsel" only Result: dismissed "1. Henkel's motion to vary the order issued orally from the bench on July 9, 2014 and signed July 10, 2014, or to stay it in part pending a formal motion to vary, is dismissed. 2. That part of the order pronounced July 9, 2014 and signed July 10, 2014, which allows in-house counsel for Novartis or its affiliates and their support staff to have access to the Henkel Information, is stayed until Wednesday, July 16, 2014, to permit Henkel or Mylan to make a motion to appeal the order of July 9 or the present order and to continue the stay pending appeal. 3. Such motion, if brought, is to be served and filed without delay, returnable on short notice at the Ottawa General Sittings of July 16, 2014, subject to the discretion of the Judge presiding at that hearing." Filed on 10-JUL-2014 copies sent to parties entered in J. & O. Book, volume 1236 page(s) 407 - 412 Interlocutory Decision
(32) 2014-07-10 - Ottawa
PRODUCTION AND CONFIDENTIALITY ORDER dated 10-JUL-2014 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 16 Result: granted Filed on 10-JUL-2014 copies sent to parties entered in J. & O. Book, volume 1236 page(s) 403 - 406 Interlocutory Decision
() 2014-07-10 - Ottawa
Letter from Applicant dated 10-JUL-2014 in response to the letter from counsel for Henkel of today's date received on 10-JUL-2014
() 2014-07-10 - Ottawa
Communication to the Court from the Registry dated 10-JUL-2014 re: letters received from counsel for Henkel and the Applicant dated 10-JUL-2014
() 2014-07-10 - Ottawa
Letter from Applicant dated 10-JUL-2014 further to the motion of July 9, 2014 attaching a draft Order agreed to by Novartis and Mylan. A draft Order is attached. received on 10-JUL-2014
() 2014-07-10 - Ottawa
Letter from counsel for Henkel Corporation dated 10-JUL-2014 with regard to the hearing of June 9, 2014 requesting an immediate direction that the Henkel Information ordered to be produced today be produced on an "outside counsel" basis. Henkel will bring a formal motion to vary the terms of the confidentiality Order for a date to be heard in the near future. Henkel is available for an emergency case conference if necessary. A decision from Court of Queen's Bench of Alberta (2014 ABQB 381) is attached. received on 10-JUL-2014
() 2014-07-09 - Ottawa
Memorandum to file from C. Bérubé, Ottawa dated 09-JUL-2014 Following the Court's Order granting standing to Henkel this morning, I have included the coordinates for Ms. Jane Caskey, counsel for Henkel by attaching a copy of her business card to this memo. placed on file.
() 2014-07-09 - Ottawa
Ottawa 09-JUL-2014 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 16 on behalf of Applicant for an Order requiring Mylan to produce unredacted documents and the omitted portions of the Henkel "Information Package" from its Abbreviated New Drug Submission within 15 days of this order to allow Novartis to properly assess Mylan's allegation of non-infringement in the within proceeding. Result of Hearing: Matter granted held in Court Senior Usher: David Lehman Duration per day: 09-JUL-2014 from 09:32 to 11:38 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Chantal Berube Total Duration: 2h6min Appearances: Mr. Marc Richard 613-233-1781 representing Applicant Mr. Alexander Gloor 613-233-1781 representing Applicant Mr. Vincent M. de Grandpré 416-862-6743 representing Respondent, Mylan Pharmaceuticals ULC Mr. Martin E. Brandsma 416-862-6790 representing Respondent, Mylan Pharmaceuticals ULC Comments: The Court (Tabib P.) issued her Order on the bench and has granted the motion (confidentiality terms have been included). Order is effective immediately. Parties to provide the formal terms of the Order as soon as possible. Court has granted standing to Henkel and parties are to include counsel for Henkel (Ms. Jane Caskey, Norton Rose, telephone: 416-216-1899) in the discussions of the terms of the Order. Audio CDs of the hearing held today was provided to counsel for the Applicant and counsel for the Respondent (Mylan) with permission of the Court. DARS was used at this hearing (Z005140). Minutes of Hearing entered in Vol. 909 page(s) 477 - 484 Abstract of Hearing placed on file
() 2014-07-08 - Ottawa
Letter from Respondent, Mylan, dated 08-JUL-2014 in response to the letter from the Applicants dated 7-JUL-2014 providing representations as to the affidavit of Sun Hee Lehmann received on 08-JUL-2014
() 2014-07-08 - Ottawa
Draft Order concerning Motion Doc. No. 16 received on 08-JUL-2014
() 2014-07-07 - Ottawa
Letter from Applicant dated 07-JUL-2014 requesting that the Affidavit of Sun Hee Lehman be struck from Mylan's motion record as the affiant was not made available for cross-examination, and despite the request of the Applicants. - scanned to the CMJ - received on 07-JUL-2014
() 2014-07-07 - Ottawa
Covering letter from Respondent dated 07-JUL-2014 concerning Doc. Nos. 30 31 placed on file on 07-JUL-2014
(31) 2014-07-07 - Ottawa
Solicitor's certificate of service on behalf of Martin Brandsma confirming service of Document #30 upon Applicant and Respondents/Patentees by personal service on 07-JUL-2014 confirming service same upon Respondent Minister of Health by email on 07-JUL-2014 filed on 07-JUL-2014
() 2014-07-07 - Ottawa
Book of Authorities consisting of 1 volume(s) on behalf of Respondent received on 07-JUL-2014
(30) 2014-07-07 - Ottawa
Motion Record in response to Motion Doc. No. 16 containing the following original document(s): 25 26 27 28 29 Number of copies received: 3 on behalf of Respondent filed on 07-JUL-2014
(29) 2014-07-07 - Ottawa
Written Representations contained within a Motion Record on behalf of Respondent concerning Motion Doc. No. 16 filed on 07-JUL-2014
(28) 2014-07-07 - Ottawa
Affidavit of Sun Hee Lehmann sworn on 01-JUL-2014 contained within a Motion Record on behalf of Respondent in opposition to Motion Doc. No. 16 with Exhibits A to C filed on 07-JUL-2014
(27) 2014-07-07 - Ottawa
Affidavit of Faylene Lunn sworn on 30-JUN-2014 contained within a Motion Record on behalf of Respondent in opposition to Motion Doc. No. 16 with Exhibits A and B filed on 07-JUL-2014
(26) 2014-07-07 - Ottawa
Affidavit of Faylene Lunn sworn on 27-JUN-2014 on behalf of Respondent in opposition to Motion Doc. No. 16 with Exhibits A to E filed on 07-JUL-2014
(25) 2014-07-07 - Ottawa
Affidavit of Sana Halvani sworn on 27-JUN-2014 contained within a Motion Record on behalf of Respondent in opposition to Motion Doc. No. 16 with Exhibits A to H filed on 07-JUL-2014
(24) 2014-06-18 - Ottawa
Affidavit of Erin McIntomny sworn on 17-JUN-2014 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 16 with Exhibits "A"-"P" filed on 18-JUN-2014
() 2014-06-27 - Ottawa
Covering letter from Applicant dated 27-JUN-2014 concerning Doc. No. 23 placed on file on 27-JUN-2014
(23) 2014-06-27 - Ottawa
Amended written representations(amending doc. 18)(served to other parties by e-mail) filed on 27-JUN-2014
() 2014-06-30 - Ottawa
Correction to General Sitting concerning Motion Doc. No. 16 Hearing added to General Sitting at Ottawa on 09-JUL-2014 at 09:30 duration: 1h Language: E Reason for correction: Further to the request from counsel received June 27, 2014
() 2014-06-27 - Ottawa
Memorandum to file from Victoria Bell - Registry Officer Ottawa dated 27-JUN-2014 the Applicant has withdrawn its request for a case management telephone conference to take place on June 30, 2014 at 9:30am and confirmed verbally with me via telephone that it would be proceeding with its motion (doc. 16) at the General Sittings in Ottawa on July 9, 2014. placed on file.
() 2014-06-27 - Ottawa
Letter from counsel for Mylan dated 27-JUN-2014 requesting that the CMC proposed in The CMJ's direction of June 26th take place to discuss the scheduling of the motion for production and timing of Applicant's testing of Mylan's product (forwarded to the CMJ by e-mail on 27-Jun-2014) received on 27-JUN-2014
() 2014-06-27 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the direction of the Court dated 26-Jun-2014 placed on file on 27-JUN-2014
() 2014-06-26 - Ottawa
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 26-JUN-2014 directing that the Court is available to hear the motion at the Ottawa general sittings on July 9, 2014, and the motion shall be heard that day unless the parties advise, by 2 pm on June 27, 2014 that they are unavailable or will not be ready to be heard that day. If the motion proceeds on July 9, the responding record is to be served and filed by 2 pm on July 7, 2014 and a CMTC will not be necessary. If a CMTC is necessary it will be held at 9:30 a.m. on June 30, 2014 placed on file on 26-JUN-2014 Confirmed in writing to the party(ies)
() 2014-06-26 - Ottawa
Letter from Applicant dated 26-JUN-2014 requesting a CMC to discuss scheduling of motion doc. no. 16 (sent to the CMJ on 26-Jun-2014) received on 26-JUN-2014
() 2014-06-19 - Ottawa
Acknowledgment of Receipt received from all parties with respect to the Order of the Court dated 13-Jun-2014 placed on file on 19-JUN-2014
() 2014-06-19 - Ottawa
Covering letter from Respondent, Mylan Pharmaceuticals ULC, dated 19-JUN-2014 concerning Doc. Nos. 21 22 placed on file on 19-JUN-2014
(22) 2014-06-20 - Ottawa
Solicitor's certificate of service on behalf of Martin Brandsma confirming service of Doc. No. 21 upon all parties by telecopier on 19-JUN-2014 filed on 20-JUN-2014
(21) 2014-06-19 - Ottawa
Notice of change of solicitor on behalf of Respondent, Mylan Pharmaceuticals ULC, filed on 19-JUN-2014
(20) 2014-06-18 - Ottawa
Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. No. 19 upon all parties by personal service on 18-JUN-2014 filed on 18-JUN-2014
(19) 2014-06-18 - Ottawa
Motion Record containing the following original document(s): 16 17 18 Number of copies received: 3 on behalf of Applicant filed on 18-JUN-2014
(18) 2014-06-18 - Ottawa
Written Representations contained within a Motion Record on behalf of Applicant concerning Motion Doc. No. 16 filed on 18-JUN-2014
(17) 2014-06-18 - Ottawa
Affidavit of Jennifer Wilkie sworn on 17-JUN-2014 contained within a Motion Record on behalf of Applicant in support of Motion Doc. No. 16 with Exhibits "A" filed on 18-JUN-2014
(16) 2014-06-18 - Ottawa
Notice of Motion contained within a Motion Record on behalf of Applicant returnable (but no hearing date indicated at this time) for an Order pursuant to s.6(7) of the Patented Medicines (NOC) Regulations requiring the Respondent, Mylan, to produce unredacted documents and other forms of relief filed on 18-JUN-2014 Draft Order\\Judgment received.
(15) 2014-06-13 - Ottawa
Order dated 13-JUN-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 12-JUN-2014 re: revised draft scheduling order Result: 1. Novartis shall serve its affidavit evidence on infringement by July 23, 2014. 2. A Requisition for Hearing shall be filed by September 22, 2014. 3. Mylan shall serve its affidavit evidence on infringement by October 31, 2014. 4. A full motion record on any motion for reply shall be filed by November 14, 2014. Such motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 5. To the extent that Mylan conducts any testing of its rivastigmine product at any point in this proceeding of which Novartis is not in receipt of the full results by at least July 1, 2014, Novartis shall have a right to serve responding evidence in response thereto within 30 days of receipt of the full results of Mylan's testing. 6. Cross-examinations shall be completed by March 2, 2015. 7. Novartis' application record shall be served and filed by March 31, 2015. 8. Mylan's Application record shall be served and filed by April 30, 2015. Filed on 13-JUN-2014 copies sent to parties entered in J. & O. Book, volume 1234 page(s) 4 - 5 Interlocutory Decision
() 2014-06-12 - Ottawa
Letter from Applicant dated 12-JUN-2014 requesting, on consent, an amendment to the timetable and attaching a draft order on consent (sent to the CMJ on 12-Jun-2014) received on 12-JUN-2014
() 2014-03-07 - Ottawa
Acknowledgment of Receipt received from all parties with respect to Protective Order Doc. 13 and Order Doc. 14: Transmitted by e-mail on 7-MAR-2014: receipt acknowledged by the Applicant and the Respondent Mylan on 7-MAR-2014; by the Respondent Minister (upon reminder) on 13-MAR-2014 placed on file on 07-MAR-2014
(14) 2014-03-06 - Ottawa
Order dated 06-MAR-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 05-MAR-2014 Result: granted "1. Novartis shall serve its affidavit evidence on infringement by 16-JUN-2014. 2. Mylan shall serve its affidavit evidence on infringement by 15-SEP-2014. 3. A Requisition for Hearing shall be filed by 22-SEP-2014. 4. A full Motion Record on any Motion for reply shall be filed by 6-OCT-2014. Such Motion shall be accompanied by a proposed schedule for filing the responding material, the expected duration of the hearing and both counsel's places and dates of availability for a hearing. 5. Cross-examinations shall be completed by 16-JAN-2015. 6. Novartis' Application Record shall be served and filed by 16-MAR-2015. 7. Mylan's Application Record shall be served and filed by 30-APR-2015." Filed on 06-MAR-2014 copies sent to parties entered in J. & O. Book, volume 1222 page(s) 182 - 183 Interlocutory Decision
(13) 2014-03-06 - Ottawa
Protective Order dated 06-MAR-2014 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Applicant dated 05-MAR-2014 Result: granted Filed on 06-MAR-2014 copies sent to parties entered in J. & O. Book, volume 1222 page(s) 171 - 181 Interlocutory Decision
() 2014-03-06 - Ottawa
Communication to the Court from the Registry dated 06-MAR-2014 re: letter dated 5-MAR-2014
() 2014-03-05 - Ottawa
Letter from Applicant dated 05-MAR-2014 re: the parties have reached agreement in respect of a proposed schedule and Protective Order. Draft orders are attached. received on 05-MAR-2014
() 2014-02-12 - Ottawa
Proof of Transmission by Fax received from All parties with respect to Doc. #12 (Order from CJC dated February 12, 2014). placed on file on 12-FEB-2014
(12) 2014-02-12 - Ottawa
Order dated 12-FEB-2014 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Status Review Result: Pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 12-FEB-2014 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1220 page(s) 2 - 2 Interlocutory Decision
(11) 2014-02-11 - Ottawa
Solicitor's certificate of service on behalf of Livia Aumand confirming service of document #10 upon Applicant by personal service on 11-FEB-2014 confirming service same upon Respondent Mylan by telecopier on 11-FEB-2014 confirming service same upon Respondent Minister of Health by telecopier on 11-FEB-2014 filed on 11-FEB-2014
(10) 2014-02-11 - Ottawa
Notice of appearance on behalf of Respondent/Patentee Novartis AG filed on 11-FEB-2014
(9) 2014-02-11 - Ottawa
Solicitor's certificate of service on behalf of Livia Aumand confirming service of Document #8 upon Applicant by personal service on 11-FEB-2014 confirming service same upon Respondent Mylan by telecopier on 11-FEB-2014 confirming service same upon Respondent Minister of Health by telecopier on 11-FEB-2014 filed on 11-FEB-2014
(8) 2014-02-11 - Ottawa
Notice of appearance on behalf of Respondent/Patentee LTS Lohmann Therapie-Systeme AG filed on 11-FEB-2014
(7) 2014-02-11 - Ottawa
Affidavit of service of Erin McIntomny sworn on 11-FEB-2014 on behalf of Applicant confirming service of Notice of Application upon Respondent Minister of Health by personal service on 06-FEB-2014 confirming service same upon Respondents/Patentees by personal service on 06-FEB-2014 confirming service same upon Respondent Mylan Pharmaceuticals ULC by process server on 10-FEB-2014 filed on 11-FEB-2014
(6) 2014-02-11 - Toronto
Solicitor's certificate of service on behalf of Sana Halwani confirming service of doc 5 upon all parties by telecopier on 11-FEB-2014 filed on 11-FEB-2014
(5) 2014-02-11 - Toronto
Notice of appearance on behalf of Respondent (Mylan) filed on 11-FEB-2014
(4) 2014-02-10 - Toronto
Affidavit of service of James Adeney sworn on 10-FEB-2014 on behalf of Respondent (Minister of Health) confirming service of Doc 3 upon all parties by telecopier on 10-FEB-2014 with Exhibits A filed on 10-FEB-2014
(3) 2014-02-10 - Toronto
Notice of appearance on behalf of Respondent (Minister of Health) filed on 10-FEB-2014
(2) 2014-02-07 - Ottawa
Service copy of Doc. No. 1 with proof of service upon Respondent on 07-FEB-2014 filed on 07-FEB-2014
(1) 2014-02-06 - Ottawa
Notice of application and 2 copies with regard to Judicial Review (s.18) returnable (but no hearing date indicated at this time) filed on 06-FEB-2014 Tariff fee of $50.00 received: yes

The official version of the court proceeding information is available from the court websites directly:
Browse another proceeding. Enter Court File No:

Canadian Intellectual Property